Mitesco (MITI) Liabilities from Discontinued Operations (2014 - 2023)
Mitesco (MITI) reported Liabilities from Discontinued Operations of 9955164.0 for Q3 2023, up 363.96% on a QoQ basis from 2145706.0 in Q4 2022.
Mitesco (MITI) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 9955164.0 in Q3 2023.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 9955164.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 9955164.0 (changed N/A YoY) and the FY2022 annual result came in at 2145706.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations rose to 9955164.0 in Q3 2023 per MITI's latest filing, from 2145706.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 9955164.0 in Q3 2023 and bottomed at 2145706.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Mitesco | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 9.96 Mn |
| Sep 30, 2023 | 9.96 Mn |
| Dec 31, 2022 | 2.15 Mn |
| Dec 31, 2022 | 2.15 Mn |
| Dec 31, 2014 | 3.10 Mn |
| Dec 31, 2014 | 3.10 Mn |